Answers are grounded in this paper and cite their sources.
Vasculopathy is a generic feature of autoimmune rheumatic disease and there is substantial evidence that endothelial cell dysfunction has a role in pathogenesis and clinical manifestations of this challenging group of diseases. Endothelial cells are a target for injury and through their essential functional role in vascular homeostasis this has significant impact. In addition, the emerging recognition that endothelial cells are important regulators of other cell types and can differentiate into other relevant cell types has direct relevance. These aspects are reviewed with a focus on recent published evidence regarding the importance of endothelial cells in development, progression, and treatment of autoimmune rheumatic disease. The potential role of the adaptive and innate immune system in causing endothelial cell damage, including anti-endothelial cell autoantibodies, will be reviewed. Recent advances in understanding how endothelial cells may differentiate into mesenchymal lineages and the interplay between physiological roles in healing or tissue repair and dysfunctional responses in acquired connective tissue disease will be reviewed.
No takes yet. Share an insight, caveat, or question.
Kanitkar et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: